Arcutis Biotherapeutics announces FDA accepted its sNDA for ZORYVE foam
PremiumThe FlyArcutis Biotherapeutics announces FDA accepted its sNDA for ZORYVE foam
2M ago
Arcutis Biotherapeutics annonnces publication of ZORYVE in JAMA Dermatology
Premium
The Fly
Arcutis Biotherapeutics annonnces publication of ZORYVE in JAMA Dermatology
2M ago
Arcutis Biotherapeutics completes enrollment of Phase 1b study on ARQ-255
Premium
The Fly
Arcutis Biotherapeutics completes enrollment of Phase 1b study on ARQ-255
2M ago
Cisco, Walmart report quarterly earnings beats: Morning Buzz
PremiumThe FlyCisco, Walmart report quarterly earnings beats: Morning Buzz
3M ago
Closing Bell Movers: Cisco jumps over 5% after Q4 earnings beat
Premium
The Fly
Closing Bell Movers: Cisco jumps over 5% after Q4 earnings beat
3M ago
Arcutis Biotherapeutics reports Q2 EPS (42c), consensus (52c)
Premium
The Fly
Arcutis Biotherapeutics reports Q2 EPS (42c), consensus (52c)
3M ago
Arcutis Biotherapeutics to host ZORYVE cream 0.15% KOL even
PremiumThe FlyArcutis Biotherapeutics to host ZORYVE cream 0.15% KOL even
4M ago
Mizuho ‘surprised’ Arcutis Biotherapeutics trading down, says buy on weakness
Premium
The Fly
Mizuho ‘surprised’ Arcutis Biotherapeutics trading down, says buy on weakness
4M ago
Arcutis Biotherapeutics trading resumes
Premium
The Fly
Arcutis Biotherapeutics trading resumes
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100